| Literature DB >> 33272229 |
Sumeyra Koyuncu1, Nevzat Herdem2, Cihan Uysal3, Guven Kahriman2, Ismail Kocyigit3, Murat Sipahioğlu3, Bulent Tokgoz3, Oktay Oymak3.
Abstract
BACKGROUND: Tunneled catheters can be used as an alternative vascular access in patients with limited health expectancy,vascular access problems and several comorbidities. We aimed to present a patient with venous stenosis related- reversible acute Budd-Chiari syndrome after catheter malposition. CASEEntities:
Keywords: Budd Chiari; Catheter; Hemodialysis; Malposition
Year: 2020 PMID: 33272229 PMCID: PMC7713328 DOI: 10.1186/s12882-020-02182-0
Source DB: PubMed Journal: BMC Nephrol ISSN: 1471-2369 Impact factor: 2.388
Fig. 1a and b In axial contrast venous phase CT section (a), the distal end of the dialysis catheter is located at the level of drainage of the hepatic veins in the inferior vena cava (black arrow) and the hypodense thrombus (black arrow) around the catheter that prevents hepatic vein drainage. In the sagittal reformat CT image, the distal of the catheter located vena cava inferior is also observed (white arrow, b)
Fig. 2In axial venous phase contrast CT section; Mosaic pattern compatible with Budd-Chiari Syndrome is observed in the liver parenchyma. No contrast agent filling is observed in the hepatic veins (black arrows). In addition, acid is observed in the perihepatic area (white arrow)
Biochemical parameters of patient before and after catheter revision
| Laboratory markers | Values | Referance values range | Units (SI) | |
|---|---|---|---|---|
| Before | After | |||
| Blood urea nitrogen | 80 | 30 | 6–20 | mg/dl |
| Creatinine | 4.4 | 2.2 | 0.5–1.2 | mg /dl |
| Sodium | 137 | 135 | 136–145 | mmol /l |
| Potassium | 3,9 | 3.5 | 3.5–5.1 | mmol/l |
| Total bilurubin | 1.1 | 0.9 | 0–1.4 | mg/dl |
| Direct bilurubin | 1.0 | 0.3 | 0–0.3 | mg/dl |
| Total protein | 51 | 50 | 64–83 | g/dL |
| Albumin | 24 | 28 | 35–52 | g/L |
| Alkaline phosphatase | 99 | 95 | 44–130 | u / L |
| Laktat dehidrogenaz | 327 | 240 | 135–250 | u / L |
| Aspartate aminotransferase | 142 | 50 | 0–40 | u / L |
| Alanine aminotransferase | 453 | 40 | 0–41 | u / L |
| Gamma glutamyl transferase | 256 | 85 | 10–71 | u / L |
| C reactive protein | 174 | 20 | 0–5 | mg /L |
| Procalcitonin | 100 | 8 | 0–0.5 | ng /dl, |
| Hemoglobin | 9.5 | 10 | 12–16 | g /dl |
| Platelet | 65,000 | 150,000 | 130–400 | μ /L |
| White blood cell | 11 × 109 | 8 × 109 | 4.8–10.7 × 109 | |
| d dimer | 4220 | 570 | 0–500 | ug/L |